Breast Cancer is the 2nd leading cause of death by cancer (Lung cancer is first) in women. In 2010, in the US alone, it is anticipated that 207,000 new cases of breast cancer in women will be diagnosed and almost 40,000 women will die of breast cancer¹. These statistics are real and sobering but there are also some heartening statistics. Studies have also shown that the 5 year survival rate for female breast cancer has increased from 63% during the ‘60s to about 90% currently based on faster and more precise diagnosis and new treatments. Discovery and validation of new markers or marker combinations accelerate improvements in diagnosis.

IMGENEX Corporation, the  leader in Tissue Microarray technology, provides the Breast Cancer Exploratory Tissue Microarray (IMA-100) as a research tool for marker analysis and development.

The Breast Cancer Exploratory Tissue Microarray (TMA) is designed as a comprehensive slide based TMA which incorporates samples of different cancerous, normal, normal adjacent, and different species of breast tissues. This includes fourteen cores of seven different immortal breast cancer cell lines along with various normal mouse and rat tissues samples. There is patient data from thirty seven individual breast cancer cases. All data is pathologist validated and includes age, sex, diagnosis, and other relevant information. The Breast Cancer Exploratory Tissue Microarray (TMA) is quality control tested with multiple stainings including Hematoxylin & Eosin, Masson’s trichrome, and antibodies to estrogen receptor and Her2/Neu.

IMGENEX has a leading selection and portfolio of Tissue Microarrays for studying cancer. IMGENEX Histo-Array™ tissue array slides are a simple, powerful, inexpensive, yet highly efficient method for expression analysis or localization studies of molecular targets at the DNA, RNA or protein level. Over ninety different human or animal tissue array slides are available, with tissue samples densities ranging from 24 to 146 spots per slide, corresponding to tissue sample sizes of 4mm to 1mm. Slides are available with different cancerous, normal, normal adjacent, or diseased tissues of different organs as well as matched tissue samples for certain slides (when noted). Each slide includes patient data on all tissue samples including age, sex, diagnosis, and any applicable staging codes. Each Histo-Array™ tissue array slide is freshly cut and packaged under anoxic conditions when you order. This ensures maximum freshness and minimal antigen loss.

For our complete offering of Tissue Microarrays and our Cancer related content  please click on the hyperlinks below.

• Apoptosis/Necroptosis
• Phosphorylation State
• Cell Signaling Molecules
• Transcription Factors
• Tumor Suppressors
• CD & Cell Surface Molecules